Search

Displaying results 7531 - 7540 of 10000 in total
  1. Drug

    Pegsitacianine

    go.drugbank.com/drugs/DB19098
    Investigational

    Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)). … Pegsitacianine is under investigation in clinical trial NCT05576974 (A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence

  2. Drug

    Gemogenovatucel-T

    go.drugbank.com/drugs/DB17412
    Investigational

    Furin is a convertase involved in the activation of TGFβ-1 and TGFβ-2.[A255163] Gemogenovatucel-T is being investigated in the treatment of various cancers.

  3. Drug

    Virginiamycin S1

    go.drugbank.com/drugs/DB04805
    Experimental

    One of the components of virginiamycin, a cyclic polypeptide antibiotic complex from streptomyces virginiae, s. Loidensis, s. Mitakaensis, s. Pristina-spiralis, s. Ostreogriseus, and others.

  4. Drug

    Inhibitor of P38 Kinase

    go.drugbank.com/drugs/DB01953
    Experimental

    Inhibitor of P38 Kinase is a solid. This compound belongs to the indoles. These are compounds containing an indole moiety, which consists of a pyrrole ring fused to benzene to form 2,3-benzopyrrole.

    Synonyms: Inhibitor of P38 Kinase
  5. Drug

    Vabametkib

    go.drugbank.com/drugs/DB21629
    Investigational

    Vabametkib has a monoisotopic molecular weight of 566.3 Da. … Vabametkib is under investigation in clinical trial NCT05541822 (To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET

  6. Drug

    Debamestrocel

    go.drugbank.com/drugs/DB17934
    Investigational

    Debamestrocel consists of autologous mesenchymal stromal cells secreting neurotrophic factors. … Debamestrocel is under clinical development by BrainStorm Cell Therapeutics and is being investigated for the treatment of Amyotrophic Lateral Sclerosis (ALS).[L47266]

  7. Drug

    Cabiotraxetan

    go.drugbank.com/drugs/DB20465
    Experimental

    The usage of the INN stem '-xetan' in the name indicates that Cabiotraxetan is a chelating agent. Cabiotraxetan has a monoisotopic molecular weight of 714.41 Da.

  8. Drug

    Cligosiban

    go.drugbank.com/drugs/DB20573
    Experimental

    The usage of the INN stem '-siban' in the name indicates that Cligosiban is a oxytocin antagonist. Cligosiban has a monoisotopic molecular weight of 419.12 Da.

  9. Drug

    Dutacatib

    go.drugbank.com/drugs/DB20890
    Experimental

    The usage of the INN stem '-catib' in the name indicates that Dutacatib is a cathepsin inhibitor. Dutacatib has a monoisotopic molecular weight of 421.26 Da.

  10. Drug

    R1295

    go.drugbank.com/drugs/DB05122
    Experimental

    R1295 is an integrin antagonist currently in clinical trials for the treatment of rheumatoid arthritis. … Integrins are associated to the pathology seen in some of the autoimmune diseases such as rheumatoid arthritis.